تميز تحفيزي
مراجع

1 2 3 4 5 6  Puglisi-Allegra S، Ventura R (يونيو 2012). "Prefrontal/accumbal catecholamine system processes high motivational salience". Front. Behav. Neurosci. ج. 6: 31. DOI:10.3389/fnbeh.2012.00031. PMC:3384081. PMID:22754514.{{استشهاد بدورية محكمة}}:  صيانة الاستشهاد: دوي مجاني غير معلم (link)
1 2 3 4  Malenka RC، Nestler EJ، Hyman SE (2009). Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (ط. 2nd). New York: McGraw-Hill Medical. ص. 147–148, 367, 376. ISBN:978-0-07-148127-4.
1 2 3 4  Schultz W (2015). "Neuronal reward and decision signals: from theories to data". Physiological Reviews. ج. 95 ع. 3: 853–951. DOI:10.1152/physrev.00023.2014. PMC:4491543. PMID:26109341.
↑  Koob GF, Moal ML (2006). Neurobiology of Addiction. Amsterdam: Elsevier/Academic Press. ص. 415. ISBN:9780080497372. مؤرشف من الأصل في 2020-01-12.
↑  Malenka RC، Nestler EJ، Hyman SE (2009). "Chapter 15: Reinforcement and Addictive Disorders". Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (ط. 2nd). New York: McGraw-Hill Medical. ص. 364–375. ISBN:9780071481274.
↑  Nestler EJ (ديسمبر 2013). "Cellular basis of memory for addiction". Dialogues Clin. Neurosci. ج. 15 ع. 4: 431–443. PMC:3898681. PMID:24459410. Despite the importance of numerous psychosocial factors, at its core, drug addiction involves a biological process: the ability of repeated exposure to a drug of abuse to induce changes in a vulnerable brain that drive the compulsive seeking and taking of drugs, and loss of control over drug use, that define a state of addiction. ... A large body of literature has demonstrated that such ΔFosB induction in D1-type [nucleus accumbens] neurons increases an animal's sensitivity to drug as well as natural rewards and promotes drug self-administration, presumably through a process of positive reinforcement ... Another ΔFosB target is cFos: as ΔFosB accumulates with repeated drug exposure it represses c-Fos and contributes to the molecular switch whereby ΔFosB is selectively induced in the chronic drug-treated state.41. ... Moreover, there is increasing evidence that, despite a range of genetic risks for addiction across the population, exposure to sufficiently high doses of a drug for long periods of time can transform someone who has relatively lower genetic loading into an addict.
↑  "Glossary of Terms". Mount Sinai School of Medicine. Department of Neuroscience. اطلع عليه بتاريخ 2015-02-09.
↑  Volkow ND، Koob GF، McLellan AT (يناير 2016). "Neurobiologic Advances from the Brain Disease Model of Addiction". N. Engl. J. Med. ج. 374 ع. 4: 363–371. DOI:10.1056/NEJMra1511480. PMID:26816013. Substance-use disorder: A diagnostic term in the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) referring to recurrent use of alcohol or other drugs that causes clinically and functionally significant impairment, such as health problems, disability, and failure to meet major responsibilities at work, school, or home. Depending on the level of severity, this disorder is classified as mild, moderate, or severe.
Addiction: A term used to indicate the most severe, chronic stage of substance-use disorder, in which there is a substantial loss of self-control, as indicated by compulsive drug taking despite the desire to stop taking the drug. In the DSM-5, the term addiction is synonymous with the classification of severe substance-use disorder.
1 2 3 4 5 6 7 8 9  Berridge KC (أبريل 2012). "From prediction error to incentive salience: mesolimbic computation of reward motivation". Eur. J. Neurosci. ج. 35 ع. 7: 1124–1143. DOI:10.1111/j.1460-9568.2012.07990.x. PMC:3325516. PMID:22487042.
1 2 3 4 5 6 7 8  Berridge KC، Kringelbach ML (مايو 2015). "Pleasure systems in the brain". Neuron. ج. 86 ع. 3: 646–664. DOI:10.1016/j.neuron.2015.02.018. PMC:4425246. PMID:25950633.
↑  Berridge، Kent C.؛ O’Doherty، John P. (1 يناير 2014). Fehr، Paul W. GlimcherErnst (المحرر). "Chapter 18 – From Experienced Utility to Decision Utility". San Diego: Academic Press: 335–351. DOI:10.1016/B978-0-12-416008-8.00018-8. ISBN:978-0-12-416008-8. {{استشهاد بدورية محكمة}}: الاستشهاد بدورية محكمة يطلب |دورية محكمة= (مساعدة)
1 2 3 4  Edwards S (2016). "Reinforcement principles for addiction medicine; from recreational drug use to psychiatric disorder". Prog. Brain Res. ج. 223: 63–76. DOI:10.1016/bs.pbr.2015.07.005. ISBN:9780444635457. PMID:26806771.
↑  Berridge, K.C., Robinson, T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev. 1998 Dec; 28(3):309–69.
1 2  Malenka RC، Nestler EJ، Hyman SE (2009). "Chapter 13: Higher Cognitive Function and Behavioral Control". Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (ط. 2nd). New York, USA: McGraw-Hill Medical. ص. 318, 321. ISBN:9780071481274.
↑  Malenka RC، Nestler EJ، Hyman SE (2009). "Chapter 10: Neural and Neuroendocrine Control of the Internal Milieu". Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (ط. 2nd). New York, USA: McGraw-Hill Medical. ص. 266. ISBN:9780071481274. Dopamine acts in the nucleus accumbens to attach motivational significance to stimuli associated with reward.
↑  Wood S، Sage JR، Shuman T، Anagnostaras SG (يناير 2014). "Psychostimulants and cognition: a continuum of behavioral and cognitive activation". Pharmacol. Rev. ج. 66 ع. 1: 193–221. DOI:10.1124/pr.112.007054. PMC:3880463. PMID:24344115.
بوابة علوم عصبية
بوابة علم النفس